BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Diabetes

Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month

Lilly is reducing the list price of insulins by: Cutting the list price of its non-branded insulin, Insulin Lispro Injection 100 units/mL, to $25&n...

March 03, 2023 | News

"Anura™ contactless health monitoring tech to integrate with mobile devices

Monitor blood pressure and predict a person's risk of pre-diabetes in just 30 seconds using only a smartphone video camera NuraLogix, a global pioneer of ...

February 27, 2023 | News

GlycoMark® test predicts diabetes risk in prediabetic individuals

A new study indicates that the GlycoMark blood test identifies high-risk, asymptomatic patients with prediabetes, not detected by standard diabetes tests, ...

February 22, 2023 | News

No More Needles: TRUMPF and RSP Systems Want to Make Blood Glucose Monitoring Easier for People with Diabetes

Partnership agreed to miniaturize a non-invasive glucose sensor for your wrist Minilaser-based technology to make life easier for diabetes patients Mor...

January 09, 2023 | News

New International Consensus on CGM Clinical Trial Metrics Aims to Spur Diabetes Treatment Advances

The groundbreaking consensus statement, endorsed by numerous leading US and international diabetes organizations, including the American Association of Cli...

December 07, 2022 | News

Life After Stroke

According to the American Stroke Association, a division of the American Heart Association, each year, approximately 800,000 people in the United...

November 22, 2022 | News

LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test

Early customers include GP offices and other community-based healthcare settings Latest figures, released as part of World Diabetes Day, reveal that 1 i...

November 15, 2022 | News

ITRI Introduces Point-of-Care AI-DR Software for Rapid Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema

The Industrial Technology Research Institute (ITRI), Taiwan's largest and one of the world's leading high-tech applied research institutions...

November 11, 2022 | News

1 in 2 diabetics suffer from Peripheral Neuropathy[1] during their lifetime : P&G

P&G Health, makers of Neurobion, embark on an effort to help people 'Put Life Back in Their Hands' for an improved quality of life. Launched...

November 08, 2022 | News

JDRF Announces Launch of Global Type 1 Diabetes Index

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the launch of the Type 1 Diabetes Index (...

September 22, 2022 | News

NuraLogix researchers announce AI models that can predict Blood Biomarker Risk

Researchers trained their machine learning based models on the facial blood flow patterns of tens of thousands of subjects who had recently received a bloo...

September 01, 2022 | News

ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis

ROKIT Healthcare, a company specializing in bio-healthcare, today announced it will provide a hyper-personalized medical platform that uses 3D bioprinting ...

August 15, 2022 | News

NuraLogix researchers announce AI models that can predict Metabolic Risks

Researchers at the company trained their machine learning based models on the facial blood flow patterns of tens of thousands of subjects who had been diag...

August 11, 2022 | News

Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings

Diabetic retinopathy is the leading cause of blindness among working-age adults globally.1 With early detection and treatment, as much as 95 percent o...

July 25, 2022 | News

Stay Connected